A detailed history of Montag A & Associates Inc transactions in Insmed Inc stock. As of the latest transaction made, Montag A & Associates Inc holds 500 shares of INSM stock, worth $35,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 631 20.76%
Holding current value
$35,300
Previous $42,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$62.0 - $79.01 $8,122 - $10,350
-131 Reduced 20.76%
500 $36,000
Q2 2024

Jul 31, 2024

BUY
$22.0 - $69.71 $13,882 - $43,987
631 New
631 $42,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.56B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.